Dr. Marie Albert, DO

NPI: 1194736793
Total Payments
$2,032
2021 Payments
$59.95
Companies
4
Transactions
9

Payment Breakdown by Category

Research$1,426 (70.2%)
Food & Beverage$605.87 (29.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1,426 2 70.2%
Food and Beverage $605.87 7 29.8%

Payments by Type

Research
$1,426
2 transactions
General
$605.87
7 transactions

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim b.v. $1,426 2 $0 (2017)
AbbVie Inc. $290.19 3 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $255.73 3 $0 (2019)
AstraZeneca Pharmaceuticals LP $59.95 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2021 $59.95 1 AstraZeneca Pharmaceuticals LP ($59.95)
2020 $101.34 1 AbbVie Inc. ($101.34)
2019 $215.51 3 AbbVie, Inc. ($188.85)
2018 $112.68 1 Boehringer Ingelheim Pharmaceuticals, Inc. ($112.68)
2017 $1,543 3 Boehringer Ingelheim b.v. ($1,426)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/28/2021 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $59.95 General
Category: Cardiovascular and Metabolism
01/14/2020 AbbVie Inc. ORILISSA (Drug) Food and Beverage In-kind items and services $101.34 General
Category: WOMENS HEALTH
08/05/2019 AbbVie, Inc. Orilissa (Drug) Food and Beverage In-kind items and services $108.54 General
Category: Endocrinology
02/10/2019 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $26.66 General
Category: DIABETES
02/05/2019 AbbVie, Inc. Orilissa (Drug) Food and Beverage In-kind items and services $80.31 General
Category: Endocrinology
02/27/2018 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $112.68 General
07/29/2017 Boehringer Ingelheim b.v. TRADJENTA (Drug) In-kind items and services $713.16 Research
Study: safety and efficacy linagliptin vs SU • Category: DIABETES
06/27/2017 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $116.39 General
02/16/2017 Boehringer Ingelheim b.v. TRADJENTA (Drug) In-kind items and services $713.16 Research
Study: safety and efficacy linagliptin vs SU • Category: DIABETES

Research Studies & Clinical Trials

Study Name Company Amount Records
safety and efficacy linagliptin vs SU Boehringer Ingelheim b.v. $1,426 2

About Dr. Marie Albert, DO

Dr. Marie Albert, DO is a Family Medicine healthcare provider based in Brewer, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194736793.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marie Albert, DO has received a total of $2,032 in payments from pharmaceutical and medical device companies, with $59.95 received in 2021. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "" ($1,426).

Practice Information

  • Specialty Family Medicine
  • Location Brewer, ME
  • Active Since 08/10/2006
  • Last Updated 04/02/2012
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1194736793

Products in Payments

  • TRADJENTA (Drug) $1,426
  • Orilissa (Drug) $188.85
  • ORILISSA (Drug) $101.34
  • FARXIGA (Drug) $59.95
  • JARDIANCE (Drug) $26.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Brewer